Abstract:Uveal melanoma (UM) is a highly metastatic cancer with resistance to immunotherapy. The present study aimed to identify novel feature genes and molecular mechanisms in UM through analysis of single‐cell sequencing data. For this purpose, data were downloaded from The Cancer Genome Atlas and National Center for Biotechnology Information Gene Expression Omnibus public databases. The statistical analysis function of the CellPhoneDB software package was used to analyze the ligand‐receptor relationships of the feature genes. The Metascape database was used to perform the functional annotation of notable gene sets. The randomForestSRC package and random survival forest algorithm were applied to screen feature genes. The CIBERSORT algorithm was used to analyze the RNA‐sequencing data and infer the relative proportions of the 22 immune‐infiltrating cell types. In vitro , small interfering RNAs were used to knockdown the expression of target genes in C918 cells. The migration capability and viability of these cells were then assessed by gap closure and Cell Counting Kit‐8 assays. In total, 13 single‐cell sample subtypes were clustered by t‐distributed Stochastic Neighbor Embedding and annotated by the R package, SingleR, into 7 cell categories: Tissue stem cells, epithelial cells, fibroblasts, macrophages, natural killer cells, neurons and endothelial cells. The interactions in NK cells|Endothelial cells, Neurons|Endothelial cells, CD74_APP, and SPP1_PTGER4 were more significant than those in the other subsets. T‐Box transcription factor 2, tropomyosin 4, plexin D1 ( PLXND1 ), G protein subunit α I2 ( GNAI2 ) and SEC14‐like lipid binding 1 were identified as the feature genes in UM. These marker genes were found to be significantly enriched in pathways such as vasculature development, focal adhesion and cell adhesion molecule binding. Significant correlations were observed between key genes and immune cells as well as immune factors. Relationships were also observed between the expression levels of the key genes and multiple disease‐related genes. Knockdown of PLXND1 and GNAI2 expression led to significantly lower viability and gap closure rates of C918 cells. Therefore, the results of the present study uncovered cell communication between endothelial cells and other cell types, identified innovative key genes and provided potential targets of gene therapy in UM.

Azacytidine treatment affects the methylation pattern of genomic and cell-free DNA in uveal melanoma cell lines

Identification of targetable epigenetic vulnerabilities in uveal melanoma

Molecular characterization of metastatic progression in patient derived xenograft models of malignant uveal melanoma

The Prognostic Landscape of Adaptive Immune Resistance Signatures and Infiltrating Immune Cells in the Tumor Microenvironment of Uveal Melanoma.

Development of New Therapeutic Options for the Treatment of Uveal Melanoma

CTLA4, PD-1, PD-L1, PD-L2, TIM-3, TIGIT, and LAG3 DNA Methylation Is Associated With BAP1-Aberrancy, Transcriptional Activity, and Overall Survival in Uveal Melanoma

Abstract 4581: Identifying class 1 HDACs as a vulnerability for aggressive uveal melanoma

Identification of feature genes and molecular mechanisms involved in cell communication in uveal melanoma through analysis of single‐cell sequencing data

Genome-Wide Methylation Patterns in Primary Uveal Melanoma: Development of MethylSig-UM, an Epigenomic Prognostic Signature to Improve Patient Stratification

Antitumor efficacy of oncolytic HSV-1 expressing cytosine deaminase is synergistically enhanced by DPD down-regulation and EMT inhibition in uveal melanoma xenograft

Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanoma

Cytotoxicity of pokeweed antiviral protein.

[Uveal Melanoma: Molecular and Genetic Mechanisms of Development and Therapeutic Approaches]

Out-patients haemophilia treatment in hospital

Targeting DNA methyltransferases for cancer therapy

Recent Advances in Molecular and Genetic Research on Uveal Melanoma

Uveal melanoma: molecular-genetic mechanisms of arising and the therapeutic approaches

Uveal Melanoma: Molecular and Genetic Mechanisms of Development and Therapeutic Approaches

miR-142-3p suppresses uveal melanoma by targeting CDC25C, TGF beta R1, GNAQ, WASL, and RAC1

Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression

Reprogramming Cells for Synergistic Combination Therapy with Nanotherapeutics against Uveal Melanoma